Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Price Performance
The stock has a market capitalization of C$21.54 million and a PE ratio of -12.66. The firm’s 50 day simple moving average is C$2.00 and its 200 day simple moving average is C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Industrial Products Stocks Investing
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- 3 Stocks to Consider Buying in October
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What is a Dividend King?
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
